COXANTO Drug Patent Profile
When do Coxanto patents expire, and when can generic versions of Coxanto launch?
Coxanto is a drug marketed by Solubiomix and is included in one NDA.
The generic ingredient in COXANTO is oxaprozin. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the oxaprozin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Coxanto
A generic version of COXANTO was approved as oxaprozin by DR REDDYS LABS LTD on January 31st, 2001.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for COXANTO?
- What are the global sales for COXANTO?
- What is Average Wholesale Price for COXANTO?
Summary for COXANTO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Patent Applications: | 4,857 |
| What excipients (inactive ingredients) are in COXANTO? | COXANTO excipients list |
| DailyMed Link: | COXANTO at DailyMed |
Pharmacology for COXANTO
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for COXANTO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solubiomix | COXANTO | oxaprozin | CAPSULE;ORAL | 217927-001 | Oct 20, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
